Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells

Experimental Biology and Medicine

Volumn 227, Issue 5, 2002, Pages 345-353

  Ahn, Eun Hyun ^a   Schroeder, Joseph J ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Ceramide; Colon cancer cells; Sphinganine; Sphingosine

Indexed keywords

CERAMIDE DERIVATIVE; SPHINGOLIPID; SPHINGOSINE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FAT INTAKE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL;

SPHINGIODEA;

EID: 0036586089     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700507     Document Type: Article

References (66)

1. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E. Sphingolipids: the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142:208-225, 1997.
2. Dillehay DL, Webb SK, Schmelz EM, Merrill AH Jr. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124:615-620, 1994.
3. Schmelz EM, Dillehay DL, Webb SK, Reiter A, Adams J, Merrill AH Jr. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56:4936-4941, 1996.
4. Schmelz EM, Bushnev AS, Dillehay DL, Liotta DC, Merrill AH Jr. Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr Cancer 28:81-85, 1997.
5. Schmelz EM, Sullards MS, Dillehay DL, Merrill AH Jr. Colonic cell proliferation and aberrant crypt formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice. J Nutr 130:522-527, 2000.
6. Schmelz EM, Roberts PC, Kustin EM, Lemonnier LA, Sullards MC, Dillehay DL, Merrill AH Jr. Modulation of intracellular β-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res 61:6723-6729, 2001.
7. Davis MA, Flaws JA, Young M, Collins K, Colburn NH. Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells. Toxicol Sci 53:48-55, 2000.
8. Veldman RJ, Klappe K, Hoekstra D, Kok JW. Metabolism and apoptotic properties of elevated ceramide in HT-29 cells. Biochem J 331:563-569, 1998.
9. Sweeney EA, Sakakura C, Shirahama T, Masamune A, Ohta H, Hakomori S-I, Yasuyuki J. Sphingosine and its methylated derivative N,N-dimethlysphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int J Cancer 66:358-366, 1996.
10. Hill MJ, Morson BC, Bussey HJR. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet 1:245-247, 1978.
11. Liu D, el-Hariry I, Karayiannakis AJ, Wilding J, Chinery R, Kmiot W, McCrea PD, Gullick WJ, Pignatelli M. Phosphorylation of β-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 77:557-563, 1997.
12. Rodrigues NR, Rowman A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 87:7555-7559, 1990.
13. Redman C, Xu MJ, Peng YM, Scott JA, Payne C, Clark LC, Nelson MA. Involvement of polyamines in selenomethionine-induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 18:1195-1202, 1997.
14. Olivier L, Cadoret A, Duluc I, Capeau J, Gespach C, Cherqui G, Freund JN. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 18:87-92, 1999.
15. Hsi LC, Baek SJ, Eling TE. Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells. Exp Cell Res 256:563-570, 2000.
16. Ilyas M, Tomlinson IPM, Rowan A, Pignatelli M, Bodmer WF. β-Catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A 94:10330-10334, 1997.
17. Schroy PC, Brown SS, Kim K, Johnson KA, Murnane MJ, Yang S, O'Brien MJ, Carney WP, Kupchik HZ. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer 76:201-209, 1995.
18. Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, Spirio L, Thliveris A, Robertson M, Egan S, Meuth M. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55:1531-1539, 1995.
19. Narayan S, Jaiswal AS. Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N-nitro-N-nitrosoguanidine requires p53. J Biol Chem 272:30619-30622, 1997.
20. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 290:989-992, 2000.
21. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A 93:4816-4820, 1996.
22. Li I-C, Chang CC, Trosko. JE. Thymidylate synthetase gene as a quantitative mutation marker in Chinese hamster cells. Mutat Res 243:233-239, 1990.
23. Mishell BB, Shiigi SM, Henry C, Chan EL, North J, Gallily R, Slomich M, Miller K, Marbrook J, Parks D. Good AH. Preparation of mouse cell suspensions. In: Mishell BB, Shiigi SM, Eds. Selected Methods in Cellular Immunology. New York: WH Freeman, pp21-23, 1980.
24. Martin D, Lenardo M. Microscopic quantitation of apoptotic index and cell viability using vital and fluorescent dyes. In: Coligan JE, Kruisbeek AM, Margulies D, Shevach EM, Strober W, Eds. Current Protocols in Immunology, New York: John Wiley & Sons, pp3.17.1-3.17.39, 1994.
25. Burton K. Determination of DNA content with diphenylamine. Methods Enzymol 12:163-166, 1968.
26. Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 172:1-16, 1994.
27. Darzynkiewicz Z, Traganos F, Melamed MR. New cell cycle compartments identified by multiparameter flow cytometry, Cytometry 1:98-108, 1980.
28. 3-induced HL-60 cell differentiation. J Biol Chem 265:15823-15831, 1990.
29. Stevens VL, Nimkar S, Jamison WCL, Liotta DC, Merrill AH Jr. Characteristics of the growth inhibition and cytotoxicity of long-chain (sphingoid) bases for Chinese hamster ovary cells: evidence for and involvement of protein kinase C. Biochem Biophys Acta 1051:37-45, 1990.
30. Stevens VL, Owens NE, Winton EF, Kinkade JM Jr, Merrill AH Jr. Modulation of retinoic acid-induced differentiation of human leukemia (HL60) cells by serum factors and sphinganine. Cancer Res 50:222-226, 1990.
31. Goldkorn T, Dressler KA, Muindi J, Radin NS, Mendelsohn J, Menaldino D, Liotta D, Kolenesnick RN. Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells: evidence that ceramide may mediate sphingosine action. J Biol Chem 266:16092-16097, 1991.
32. Endo K, Igarashi Y, Nisar M, Zhou Q, Hakomori SI. Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res 51:1613-1618, 1991.
33. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 259:1769-1771, 1993.
34. 1 in HT-29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol Appl Pharm 148:252-260, 1998.
35. Smith ER, Merrill AH Jr. Differential roles of de novo sphingolipid biosynthesis and turnover in the burst of free sphingosine and sphinganine, and their 1-phosphates and N-acyl derivatives that occurs upon changing the medium of cells in culture. J Biol Chem 270:18749-18758, 1995.
36. Smith ER, Jones PL, Boss JM, Merrill AH Jr. Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. J Biol Chem 272:5640-5646, 1997.
37. Warden L-A, Menaldino D-S, Wilson T, Liotta D-C, Smith E-R, Merrill A-H. Identification of ammonium ion and 2,6-bis(ω-aminobutyl)-3, 5-diiminopiperazine as endogenous factors that account for the "burst" of sphingosine upon changing the medium of J774 cells in culture. J Biol Chem 274:33875-33880, 1999.
38. Schmelz EM, Crall KJ, Larocque R, Dillehay DL, Merrill AH Jr. Uptake and metabolism of sphingolipids in isolated intestinal loops. J Nutr 124:702-712, 1994.
39. Nilsson A. Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim Biophys Acta 164:575-584, 1968.
40. Nilsson A. Metabolism of cerebrosides in the intestinal tract of the rat. Biochim Biophys Acta 187:113-121, 1969.
41. Imaizumi K, Tominaga A, Sato M, Sugano M. Effects of dietary sphingolipids on levels of serum and liver lipids in rats. Nutr Res 12:543-548, 1992.
42. Bielawaska A, Crane HM, Liotta DC, Obeid LM, Hannun YA. Selectivity of ceramide-mediated biology: lack of activity of erythrodihydrocermiade. J Biol Chem 268:26226-26232, 1993.
43. Tepper CL, Jayadev S, Liu B, Bielawska A, Wolff RA, Yonehara S, Hannun YA, Seldin MF. Role for ceramide as an endogenous mediator of fas-induced cytotoxicity. Proc Natl Acad Sci U S A 92:8443-8447, 1995.
44. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishikura H, Umehara H, Domae N. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 270:27326-27331, 1995.
45. Brugg B, Michel PP, Agid Y, Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 66:733-739, 1996.
46. Karasavvas N, Erukulla RK, Bittman R, Lockshin R, Zakeri Z. Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. Eur J Biochem 236:729-737, 1996.
47. Xu J, Yeh C-H, Chen S, He L, Sensi SL, Canzoniero LMT, Choi DW, Hsu CY. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 273:16521-16526, 1998.
48. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S, Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 55:691-697, 1995.
49. Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, Bittman R, Grant S. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J Biol Chem 271:8275-8284, 1996.
50. Ahn EH, Schroeder JJ. Bioactive sphingolipids are constituents of soy and dairy products. J Food Sci 67:2002.
51. Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B. Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 55:53-64, 1998.
52. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57:2452-2459, 1997.
53. Waddell WR. Stimulation of apoptosis by sulindac and piroxicam. Clin Sci 95:385-388, 1998.
54. Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. J Surg Res 81:101-107, 1999.
55. Chan TA, Morin PJ, Kinzler KW. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95:681-686, 1998.
56. Del Bino G, Darzynkiewicz Z. Camptothecin and teniposide, or 4′-(9-acridinylamino)-3-methane-sulfon-m-anisidide, but not mitoxantrone or doxorubucun, induces degradation of nuclear DNA in the S phase of HL-60 cells. Cancer Res 51:1165-1169, 1991.
57. Gorczyca W, Gong J, Ardelt B, Tragances F, Darzynkiewicz Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53:3186-3192, 1993.
58. 2 phase arrest in human breast cancer grated in nude mice. Anticancer Res 16:2699-2704, 1996.
59. Olivier M, Bautista S, Vallès H, Theillet C. Relaxed cell cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53. Mol Carcinog 23:1-12, 1998.
60. Huang RFS, Ho YH, Lin HL, Wei JS, Liu, TZ. Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells. J Nutr 129:25-31, 1999.
61. 2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr Cancer 30:169-174, 1998.
62. Knowles LM, Milner JA. Possible mechanism by which allyl sulfides suppress neoplastic cell proliferation. J Nutr 131:1061S-1066S, 2001.
63. Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA. p53-dependent ceramide response to genotoxic response. J Clin Invest 102:329-339, 1998.
64. Carethers JM, Pham TTT. Mutations of transforming growth factor-β-1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines. In Vivo Attiki 14:13-20, 2000.
65. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 290:989-992, 2000.
66. Kim JH, Oh SO, Jun SS, Jung JS, Woo JS, Kim YK, Lee SH. Activation of SAPK and increase in Bak levels during ceramide and indomethacin-induced apoptosis in HT29 cells. Korean J Physiol Pharmacol 3:75-82, 1999.